![](/img/cover-not-exists.png)
Clinical surrogate markers of survival in advanced non-small cell lung cancer (NSCLC) patients treated with second–third line erlotinib
Cedrés, Susana, Prat, Aleix, Martínez, Pablo, Pallisa, Esther, Sala, Gemma, Andreu, Jordi, del Campo, J.M., Quispe, Isela, Baselga, José, Felip, EnriquetaVolume:
66
Language:
english
Journal:
Lung Cancer
DOI:
10.1016/j.lungcan.2009.01.014
Date:
November, 2009
File:
PDF, 341 KB
english, 2009